Muhammad Nawaz


Avd för reumatologi och
Guldhedsgatan 10A
413 46 Göteborg
Box 480
405 30 Göteborg

Om Muhammad Nawaz

Dr. Nawaz received his first diploma in Bachelor of Science in Chemistry and Biology (BSc, 2006), and Master's degree in Biochemistry & Molecular Biology (2009) with specialization in genetics, nucleic acids metabolism, protein chemistry and DNA recombinant biotechnology. In 2011, he completed M.Phil/MS thesis on inherited / congenital diseases with a particular focus on intellectual disability and cognition (neurological disorders). He obtained PhD degree from the University of Sao Paulo, Brazil (2013-2017) where he investigated the role of microRNAs in malignant progression of brain tumors (gliomas), with an aim to identify potential therapeutic targets and non-invasive biomarkers. Along with his supervisor he also wrote a project to apply liposomes for transporting oligonucleotides (anti-miRs as silencing RNAs) to glioma cells, which was approved and funded by Brazilian health ministry - National Support Program for Oncology Care (PRONON).

During his PhD, he wrote an independent project for PhD exchange to go abroad and joined Hadi Valadi lab at the University of Gothenburg, where he worked on exosomes. The project was funded by CAPSES - Brazilian funding agency. After completing PhD degree in 2017, Dr. Nawaz then continued as a postdoc.

During his postdoc at Valadi Lab, Dr. Nawaz was involved in collaborative projects in partnership with AstraZeneca for developing RNA drug delivery systems (particularly mRNA-based therapy using lipid nanoparticles and exosomes). The collaborative work was published in "Nature Communications". Link to publication!

Currently, Dr. Nawaz is working as Forskare (Senior researcher) at the Valadi Lab, with projects funded by "Vinnova" (Swedish Government's Agency for Innovation Systems), for developing new methods of RNA drug delivery and tools of stem cell-based therapies and organ repairs. He also works with "RNA/nucleotide Therapeutics Consortium" established between 3 Universities and different Biotech companies. The Consortium is funded by "Swedish Foundation for Strategic Research". RNA-based therapeutics, which function either by silencing pathological genes through delivery of siRNA or expressing therapeutic proteins through the delivery of exogenous mRNA to cells — hold great potential for the treatment of various diseases including cancer, infectious diseases, and various inherited genetic diseases. RNA therapy provides potential new treatment options in multiple diseases and has been tested in clinical trials of several diseases, and lately applied in COVID-19 RNA vaccines.

He has received national and international research and travel grants, scholarships from Brazil and Sweden, and have participated in several national and international conferences. He also serves as peer reviewer (Publons profile) for web of science (WOS) indexed journals and help publishers and editors in peer review process.

According to Dr. Nawaz, he loves to build networking with peers having long sought socio-scientific motives to make an impact on society. He believes that learning is never ending process, and thinks that getting resources from society might be easy for us but giving back to society might be often hard (you need to be more open for that). One should be able to reciprocate or pay back to society. It can be done in many forms, and according to him the best form is is knowledge sharing, and transferring the experiences, skill transfer, rendering some free services, especially to those who are in need or those who cannot afford or lack resources. Knowledge belongs to society, not to individuals.

For the works he has presented, see this link on YouTube


Nawaz on Twitter: